Gamma interferon: a central mediator in atherosclerosis

[1]  A. Sabirsh,et al.  Pro‐ and anti‐inflammatory substances modulate expression of the leukotriene B4 receptor, BLT1, in human monocytes , 2005, Journal of leukocyte biology.

[2]  Xinghua Zhou,et al.  IL-18 Accelerates Atherosclerosis Accompanied by Elevation of IFN-&ggr; and CXCL16 Expression Independently of T Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Aseem Kumar,et al.  Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts. , 2005, Biochemical and biophysical research communications.

[4]  J. Keaney,et al.  Cytokine-Stimulated GTP Cyclohydrolase I Expression in Endothelial Cells Requires Coordinated Activation of Nuclear Factor-&kgr;B and Stat1/Stat3 , 2005, Circulation research.

[5]  A. Langheinrich,et al.  Atherosclerosis: humoral and cellular factors of inflammation , 2005, Virchows Archiv.

[6]  M. Lotze,et al.  Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1. , 2005, Molecular immunology.

[7]  G. Stark,et al.  Role of Tyrosine 441 of Interferon-γ Receptor Subunit 1 in SOCS-1-mediated Attenuation of STAT1 Activation* , 2005, Journal of Biological Chemistry.

[8]  G. Getz.  Thematic review series: The Immune System and Atherogenesis. Immune function in atherogenesis Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.R400013-JLR200 , 2005, Journal of Lipid Research.

[9]  L. Norgren,et al.  The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma. , 2004, Biochemical and biophysical research communications.

[10]  C. D. Krause,et al.  Interferons, interferon‐like cytokines, and their receptors , 2004, Immunological reviews.

[11]  M. Isobe,et al.  HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation. , 2004, Cardiovascular research.

[12]  N. Weintraub,et al.  Antioxidant effects of statins. , 2004, Drugs of today.

[13]  U. Hempel,et al.  Glycogen synthase kinase‐3β negatively regulates group IIA phospholipase A2 expression in human aortic smooth muscle and HepG2 hepatoma cells , 2004, FEBS letters.

[14]  B. Cronstein,et al.  Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[15]  J. Loike,et al.  Statin Inhibition of Fc Receptor–Mediated Phagocytosis by Macrophages Is Modulated by Cell Activation and Cholesterol , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Yun Bai,et al.  Lovastatin modulation of microglial activation via suppression of functional CD40 expression , 2004, Journal of neuroscience research.

[17]  Yulan Qing,et al.  Alternative Activation of STAT1 and STAT3 in Response to Interferon-γ* , 2004, Journal of Biological Chemistry.

[18]  K. Labuzek,et al.  The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipidemia. , 2004, Atherosclerosis.

[19]  W. Sessa,et al.  T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. , 2004, The Journal of clinical investigation.

[20]  Richard T. Lee,et al.  Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. , 2004, The Journal of clinical investigation.

[21]  A. Kumar,et al.  Down‐regulation of CXCR‐4 and CCR‐5 expression by interferon‐γ is associated with inhibition of chemotaxis and human immunodeficiency virus (HIV) replication but not HIV entry into human monocytes , 2004, Clinical and experimental immunology.

[22]  C. Haslett,et al.  Interferon γ suppresses glucocorticoid augmentation of macrophage clearance of apoptotic cells , 2004, European journal of immunology.

[23]  F. Mach.  Statins as immunomodulatory agents. , 2004, Circulation.

[24]  N. Kalinina,et al.  Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[25]  U. Hedin,et al.  CXCL16/SR-PSOX Is an Interferon-&ggr;–Regulated Chemokine and Scavenger Receptor Expressed in Atherosclerotic Lesions , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[26]  W. Alexander,et al.  The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. , 2004, Annual review of immunology.

[27]  William R. Burns,et al.  Interferon‐γ plays a nonredundant role in mediating T‐cell‐ dependent outward vascular remodeling of allogeneic human coronary arteries , 2004 .

[28]  T. Greiner,et al.  Key Roles of CD4+ T Cells and IFN-γ in the Development of Abdominal Aortic Aneurysms in a Murine Model1 , 2004, The Journal of Immunology.

[29]  J. Suttles,et al.  Role of Leukotriene B4 Receptors in the Development of Atherosclerosis: Potential Mechanisms , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[30]  T. Imaizumi,et al.  Heparin Inhibits IFN-γ-Induced Fractalkine/CX3CL1 Expression in Human Endothelial Cells , 2004, Inflammation.

[31]  Shailendra Giri,et al.  Potential Targets of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor for Multiple Sclerosis Therapy , 2004, The Journal of Immunology.

[32]  G. Reibnegger,et al.  Modulation of LDL Oxidation by 7,8-Dihydroneopterin , 2004, Free radical research.

[33]  Wan-Wan Lin,et al.  Statins induce suppressor of cytokine signaling‐3 in macrophages , 2003, FEBS letters.

[34]  T. Toyo-Oka,et al.  Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development , 2003, Circulation research.

[35]  P. Libby,et al.  Direct Anti-Inflammatory Mechanisms Contribute to Attenuation of Experimental Allograft Arteriosclerosis by Statins , 2003, Circulation.

[36]  M. Wynes,et al.  Induction of Macrophage Insulin-Like Growth Factor-I Expression by the Th2 Cytokines IL-4 and IL-131 , 2003, The Journal of Immunology.

[37]  J. Mitchell,et al.  Role for Nuclear Factor-κB and Signal Transducer and Activator of Transcription 1/Interferon Regulatory Factor-1 in Cytokine-Induced Endothelin-1 Release in Human Vascular Smooth Muscle Cells , 2003 .

[38]  F. Mach,et al.  Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins. , 2003, Autoimmunity reviews.

[39]  F. Mach.  Statins as novel immunomodulators: From cell to potential clinical benefit , 2003, Thrombosis and Haemostasis.

[40]  T. Lüscher,et al.  Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. , 2003, Cardiovascular research.

[41]  Wan-Wan Lin,et al.  HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages. , 2003, Journal of biomedical science.

[42]  D. Granger,et al.  Role of Interferon-&ggr; in Hypercholesterolemia-Induced Leukocyte–Endothelial Cell Adhesion , 2003, Circulation.

[43]  K. Tracey,et al.  IFN-γ Induces High Mobility Group Box 1 Protein Release Partly Through a TNF-Dependent Mechanism1 , 2003, The Journal of Immunology.

[44]  D. Fuchs,et al.  Atorvastatin suppresses interferon‐γ‐induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines , 2003, Clinical and experimental immunology.

[45]  K. Ozato,et al.  Complex Formation of the Interferon (IFN) Consensus Sequence-binding Protein with IRF-1 Is Essential for Murine Macrophage IFN-γ-induced iNOS Gene Expression* , 2003, The Journal of Biological Chemistry.

[46]  A. Rudensky,et al.  Differential Regulation of Cathepsin S and Cathepsin L in Interferon γ–treated Macrophages , 2003, Journal of Experimental Medicine.

[47]  Satoru Shiono,et al.  Control mechanism of JAK/STAT signal transduction pathway , 2003, FEBS letters.

[48]  E. Ikonen,et al.  Macrophage cholesterol transport: a critical player in foam cell formation , 2003, Annals of medicine.

[49]  Young Kun Kim,et al.  Statin inhibits interferon-γ-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells , 2002, Experimental & Molecular Medicine.

[50]  D. Novick,et al.  The promoter of IL-18 binding protein: Activation by an IFN-γ-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein β , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Youssef,et al.  The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease , 2002, Nature.

[52]  M. Hecker,et al.  3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase-Independent Inhibition of CD40 Expression by Atorvastatin in Human Endothelial Cells , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[53]  A. Siegbahn,et al.  Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin. , 2002, Thrombosis research.

[54]  Ira Tabas,et al.  Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. , 2002, The Journal of clinical investigation.

[55]  Robin M. Hochstrasser,et al.  Seeing the Light , 2002, Molecular & Cellular Proteomics.

[56]  P. Libby,et al.  Cytokines Induce Indoleamine 2,3-Dioxygenase Expression in Human Atheroma-Associated Cells: Implications for Persistent Chlamydophila pneumoniae Infection , 2002, Infection and Immunity.

[57]  Michael R. Müller,et al.  Simvastatin Reduces Expression of Cytokines Interleukin-6, Interleukin-8, and Monocyte Chemoattractant Protein-1 in Circulating Monocytes From Hypercholesterolemic Patients , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[58]  G. Beresford,et al.  Kinetics of a Gamma Interferon Response: Expression and Assembly of CIITA Promoter IV and Inhibition by Methylation , 2002, Molecular and Cellular Biology.

[59]  Y. Hattori,et al.  Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells. , 2002, Cardiovascular research.

[60]  S. Zuckerman,et al.  Interferon-&ggr;–Mediated Downregulation of Cholesterol Efflux and ABC1 Expression Is by the Stat1 Pathway , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[61]  D. Hilton,et al.  Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with SOCS-1 , 2002, Molecular and Cellular Biology.

[62]  L. Santambrogio,et al.  IFN Regulatory Factor-1 Regulates IFN-γ-Dependent Cathepsin S Expression1 , 2002, The Journal of Immunology.

[63]  Dan Yang,et al.  Cooperation of STAT-1 and IRF-1 in Interferon-γ-induced Transcription of the gp91 phox Gene* , 2002, The Journal of Biological Chemistry.

[64]  J. Pober,et al.  Activation of Signal Transducer and Activator of Transcription 1 (STAT1) Is Not Sufficient for the Induction of STAT1-dependent Genes in Endothelial Cells , 2002, The Journal of Biological Chemistry.

[65]  H. Showell,et al.  Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[66]  A. Daugherty,et al.  Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E−/− Mice Through Release of Interferon-&ggr; , 2002, Circulation research.

[67]  J. Pepper,et al.  Cytokine modulation of granulocyte macrophage-CSF and granulocyte-CSF release from stimulated vascular smooth muscle cells. , 2002, European journal of pharmacology.

[68]  Chilakamarti V. Ramana,et al.  Stat1-dependent and -independent pathways in IFN-γ-dependent signaling , 2002 .

[69]  James L. Young,et al.  Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages , 2002, The Journal of experimental medicine.

[70]  M. Hecker,et al.  Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1. , 2002, Blood.

[71]  P. Groot,et al.  Fractalkine Is Expressed by Smooth Muscle Cells in Response to IFN-γ and TNF-α and Is Modulated by Metalloproteinase Activity1 , 2002, The Journal of Immunology.

[72]  P. Libby,et al.  CD40 Signaling and Plaque Instability , 2001, Circulation research.

[73]  B. Cronstein,et al.  Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. , 2001, Journal of lipid research.

[74]  T. Oite,et al.  Expression of adhesion molecules by cultured human glomerular endothelial cells in response to cytokines: comparison to human umbilical vein and dermal microvascular endothelial cells. , 2001, Microvascular research.

[75]  A. Koch,et al.  A Novel Role for Interleukin-18 in Adhesion Molecule Induction through NFκB and Phosphatidylinositol (PI) 3-Kinase-dependent Signal Transduction Pathways* , 2001, The Journal of Biological Chemistry.

[76]  G. Stark,et al.  Roles of Phosphatidylinositol 3-Kinase in Interferon-γ-dependent Phosphorylation of STAT1 on Serine 727 and Activation of Gene Expression* , 2001, The Journal of Biological Chemistry.

[77]  Zhi-jun Duan,et al.  Synergistic Transcriptional Activation of HumanAcyl-coenzyme A: Cholesterol Acyltransterase-1 Gene by Interferon-γ and All-trans-Retinoic Acid THP-1 Cells* , 2001, The Journal of Biological Chemistry.

[78]  Chilakamarti V. Ramana,et al.  Biologic consequences of Stat1-independent IFN signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[79]  Richard M. Ransohoff,et al.  Stat1-independent regulation of gene expression in response to IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[80]  T. Taniguchi,et al.  The interferon system and interferon regulatory factor transcription factors -- studies from gene knockout mice. , 2001, Cytokine & growth factor reviews.

[81]  R. Pardi,et al.  Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. , 2001, Transplantation.

[82]  Xinghua Zhou,et al.  Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell. , 2001, Immunology.

[83]  L. Bernier,et al.  Identification of a &ggr;-Interferon-Responsive Element in the Promoter of the Human Macrophage Scavenger Receptor A Gene , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[84]  S. Minoguchi,et al.  The SOCS Box of SOCS-1 Accelerates Ubiquitin-dependent Proteolysis of TEL-JAK2* , 2001, The Journal of Biological Chemistry.

[85]  I. Charo,et al.  Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice , 2001, Current opinion in lipidology.

[86]  T. Kodama,et al.  Evidence of Macrophage Foam Cell Formation by Very Low-Density Lipoprotein Receptor: Interferon-&ggr; Inhibition of Very Low-Density Lipoprotein Receptor Expression and Foam Cell Formation in Macrophages , 2001, Circulation.

[87]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[88]  G. Pistritto,et al.  Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing α5β1 integrin expression and function , 2001 .

[89]  F. Mach,et al.  Statins as a newly recognized type of immunomodulator , 2000, Nature Medicine.

[90]  A. Daugherty,et al.  Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice , 2000 .

[91]  R. Alon,et al.  Autocrine Secretion of Interferon γ Negatively Regulates Homing of Immature B Cells , 2000, The Journal of experimental medicine.

[92]  J. Ramirez,et al.  Inhibition of Chlamydia pneumoniaeReplication in Human Aortic Smooth Muscle Cells by Gamma Interferon-Induced Indoleamine 2,3-Dioxygenase Activity , 2000, Infection and Immunity.

[93]  C. Cardozo,et al.  Control of LMP7 expression in human endothelial cells by cytokines regulating cellular and humoral immunity. , 2000, Cytokine.

[94]  S. Marklund,et al.  Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. , 2000, Atherosclerosis.

[95]  K. Ozato,et al.  Interferon Regulatory Factor (Irf)-1 and Irf-2 Regulate Interferon γ–Dependent Cyclooxygenase 2 Expression , 2000, The Journal of experimental medicine.

[96]  S. Zuckerman,et al.  Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[97]  M. Fujimoto,et al.  IFN Regulatory Factor-1-Mediated Transcriptional Activation of Mouse STAT-Induced STAT Inhibitor-1 Gene Promoter by IFN-γ1 , 2000, The Journal of Immunology.

[98]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[99]  Y. Song,et al.  Regulation of lysyl oxidase by interferon-gamma in rat aortic smooth muscle cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[100]  W. März,et al.  HMG-CoA Reductase Inhibition: Anti-Inflammatory Effects beyond Lipid Lowering? , 2000, Herz.

[101]  T. Suhara,et al.  Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[102]  MasatakaSata,et al.  Vascular Endothelial Cells and Smooth Muscle Cells Differ in Expression of Fas and Fas Ligand and in Sensitivity to Fas Ligand–Induced Cell Death , 2000 .

[103]  Mikhail Chernov,et al.  Regulation of c‐myc expression by IFN‐γ through Stat1‐dependent and ‐independent pathways , 2000 .

[104]  J. Pober,et al.  Interferon-γ elicits arteriosclerosis in the absence of leukocytes , 2000, Nature.

[105]  T. Langmann,et al.  Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.

[106]  P. Libby,et al.  Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. , 1999, The Journal of clinical investigation.

[107]  A. Yoshimura,et al.  SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality , 1999, Cell.

[108]  A. Sugawara,et al.  Transcriptional suppression of rat angiotensin AT1a receptor gene expression by interferon-gamma in vascular smooth muscle cells. , 1999, Biochemical and biophysical research communications.

[109]  P. Cullen,et al.  Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[110]  K. H. Leung.  Release of soluble ICAM-1 from human lung fibroblasts, aortic smooth muscle cells, dermal microvascular endothelial cells, bronchial epithelial cells, and keratinocytes. , 1999, Biochemical and biophysical research communications.

[111]  P. Sartipy,et al.  CD44, a Cell Surface Chondroitin Sulfate Proteoglycan, Mediates Binding of Interferon-γ and Some of Its Biological Effects on Human Vascular Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.

[112]  U. Andersson,et al.  Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. , 1999, Atherosclerosis.

[113]  T. Taniguchi,et al.  Protein tyrosine kinase Pyk2 mediates the Jak‐dependent activation of MAPK and Stat1 in IFN‐γ, but not IFN‐α, signaling , 1999 .

[114]  H. Dickensheets,et al.  Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1 , 1999 .

[115]  G. Feng,et al.  Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/STAT Pathway , 1999, Molecular and Cellular Biology.

[116]  A. Yoshimura,et al.  The JAK‐binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop , 1999, The EMBO journal.

[117]  K. Shuai,et al.  The Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 but Not SOCS2 Proteins Inhibit Interferon-mediated Antiviral and Antiproliferative Activities* , 1998, The Journal of Biological Chemistry.

[118]  W. Min,et al.  Interferon Induction of TAP1: The Phosphatase SHP-1 Regulates Crossover Between the IFN-α/β and the IFN-γ Signal-Transduction Pathways , 1998 .

[119]  S. Akira,et al.  IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. , 1998, Journal of immunology.

[120]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[121]  E. Berg,et al.  IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells. , 1998, Journal of immunology.

[122]  D. Chang,et al.  Inhibition of Stat1-mediated gene activation by PIAS1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[123]  E. Berg,et al.  IFN-γ Inhibits Activation-Induced Expression of E- and P-Selectin on Endothelial Cells , 1998, The Journal of Immunology.

[124]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[125]  P. Libby,et al.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. , 1998, The Journal of clinical investigation.

[126]  K. Matsumoto,et al.  Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[127]  V. Bittner.  Atherosclerosis and the immune system. , 1998, Archives of internal medicine.

[128]  Klaus Eichmann,et al.  Murine Macrophages Secrete Interferon γ upon Combined Stimulation with Interleukin (IL)-12 and IL-18: A Novel Pathway of Autocrine Macrophage Activation , 1998, The Journal of experimental medicine.

[129]  G. Hansson,et al.  Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. , 1998, The Journal of clinical investigation.

[130]  A. Sica,et al.  Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. , 1998, Journal of immunology.

[131]  E. Ohlstein,et al.  Chemokine Receptors in Human Endothelial Cells , 1998, The Journal of Biological Chemistry.

[132]  M. Russell,et al.  Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. , 1998, The American journal of pathology.

[133]  G. Baumann,et al.  Regulation of Tumor Necrosis Factor-α and Interleukin-1β Induced Adhesion Molecule Expression in Human Vascular Smooth Muscle Cells by cAMP , 1997 .

[134]  M. Leinonen,et al.  Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[135]  P. Libby,et al.  Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. , 1997, The Journal of clinical investigation.

[136]  P. Cresswell,et al.  Interferon-γ Rapidly Increases Peptide Transporter (TAP) Subunit Expression and Peptide Transport Capacity in Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[137]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[138]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[139]  K. Murao,et al.  Regulation of Expression of the Human Monocyte Chemotactic Protein-1 Receptor (hCCR2) by Cytokines* , 1997, The Journal of Biological Chemistry.

[140]  P. Libby,et al.  Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[141]  R. Dean,et al.  Regulation of serum-induced lipid accumulation in human monocyte-derived macrophages by interferon-gamma. Correlations with apolipoprotein E production, lipoprotein lipase activity and LDL receptor-related protein expression. , 1997, Atherosclerosis.

[142]  P. Halloran,et al.  The unique role of interferon-gamma in the regulation of MHC expression on arterial endothelium. , 1996, Transplantation.

[143]  P. Libby,et al.  Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon- , 1996, The Journal of Biological Chemistry.

[144]  S. Vandenberg,et al.  Transcriptional regulation of LDL receptor‐related protein by IFN‐γ and the antagonistic activity of TGF‐β1 in the RAW 264.7 macrophage‐like cell line , 1996, Journal of leukocyte biology.

[145]  G. Stark,et al.  Kinase‐negative mutants of JAK1 can sustain interferon‐gamma‐inducible gene expression but not an antiviral state. , 1996, The EMBO journal.

[146]  P. Marsden,et al.  Vascular endothelial platelet endothelial adhesion molecule-1 (PECAM-1) expression is decreased by TNF-alpha and IFN-gamma. Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. , 1996, Journal of immunology.

[147]  A. Hoffbrand,et al.  Induction of tissue factor expression in human monocyte/endothelium cocultures , 1995, British journal of haematology.

[148]  M. Bruzelius,et al.  Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[149]  G. Bondjers,et al.  Interferon gamma binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular response. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[150]  W. Windsor,et al.  Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor , 1995, Nature.

[151]  C. Rock,et al.  Deregulated c-myc expression overrides IFN gamma-induced macrophage growth arrest. , 1995, Oncogene.

[152]  J. Darnell,et al.  Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway , 1995, Science.

[153]  T. Mosmann,et al.  Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. , 1995, Immunity.

[154]  R. Strieter,et al.  Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. , 1994, The American journal of pathology.

[155]  I. Tabas,et al.  Interferon-gamma down-regulates the lipoprotein(a)/apoprotein(a) receptor activity on macrophage foam cells. Evidence for disruption of ligand-induced receptor recycling by interferon-gamma. , 1994, The Journal of biological chemistry.

[156]  G. Evan,et al.  Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest? , 1994, The Biochemical journal.

[157]  A. Wilks,et al.  Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. , 1994, The Journal of biological chemistry.

[158]  B. Viviano,et al.  Ligand‐induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). , 1994, The EMBO journal.

[159]  D. Beier,et al.  Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene , 1993, Cell.

[160]  P. Quesenberry,et al.  Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma. , 1993, The Journal of clinical investigation.

[161]  S. Zuckerman,et al.  Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-beta. , 1992, Atherosclerosis.

[162]  G. Hansson,et al.  Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. , 1992, The Journal of clinical investigation.

[163]  A. Mantovani,et al.  Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. , 1992, Journal of immunology.

[164]  P. Libby,et al.  Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[165]  G. Bondjers,et al.  Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages. , 1990, Biochimica et biophysica acta.

[166]  Leonard,et al.  Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. , 1990, The American journal of pathology.

[167]  G. Hansson,et al.  MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin. , 1990, Immunology.

[168]  G. Gabbiani,et al.  Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells , 1989, The Journal of experimental medicine.

[169]  G. Hansson,et al.  Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.

[170]  P. Libby,et al.  Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[171]  A. Clowes,et al.  Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. , 1988, Circulation research.

[172]  W. Buurman,et al.  Effects of tumor necrosis factor on the interferon‐γ‐induced major histocompatibility complex class II antigen expression by human endothelial cells , 1988 .

[173]  N. Sigal,et al.  Regulation of class II MHC molecules on human endothelial cells. Effects of IFN and dexamethasone. , 1988, Journal of immunology.

[174]  D E McMillan,et al.  Blood flow and the localization of atherosclerotic plaques. , 1985, Stroke.

[175]  A. Celada,et al.  Regulation of murine Tap1 and Lmp2 genes in macrophages by interferon gamma is mediated by STAT1 and IRF-1 , 2004, Genes and Immunity.

[176]  G. Getz.  Immune function in atherogenesis , 2004 .

[177]  T. Imaizumi,et al.  Heparin inhibits IFN-gamma-induced fractalkine/CX3CL1 expression in human endothelial cells. , 2004, Inflammation.

[178]  K. Tracey,et al.  IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. , 2003, Journal of immunology.

[179]  L. Wahl,et al.  Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. , 2003, The Journal of biological chemistry.

[180]  Y. Hattori,et al.  3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Enhance Cytokine-mediated Induction of Nitric Oxide Synthesis in Vascular Smooth Muscle Cells , 2002 .

[181]  L. Santambrogio,et al.  IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression. , 2002, Journal of immunology.

[182]  T. Taniguchi,et al.  IRF family of transcription factors as regulators of host defense. , 2001, Annual review of immunology.

[183]  S. Zuckerman,et al.  Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-gamma. , 2000, Journal of lipid research.

[184]  G R Stark,et al.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. , 2000, The EMBO journal.

[185]  S. Milstien,et al.  Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[186]  W. Min,et al.  Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-alpha/beta and the IFN-gamma signal-transduction pathways. , 1998, Circulation research.

[187]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[188]  A. Tall,et al.  IFN- g Potentiates Atherosclerosis in ApoE Knock-out Mice , 1997 .

[189]  G. Baumann,et al.  Regulation of tumor necrosis factor alpha- and interleukin-1-beta-induced induced adhesion molecule expression in human vascular smooth muscle cells by cAMP. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[190]  W. Reith,et al.  Regulation of MHC class II genes: lessons from a disease. , 1996, Annual review of immunology.

[191]  P. Libby,et al.  Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β , 1996 .

[192]  P. Libby,et al.  Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[193]  P. Libby,et al.  Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. , 1995, The Journal of clinical investigation.

[194]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[195]  H. Kuhn,et al.  Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[196]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[197]  W. Buurman,et al.  Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells. , 1988, European journal of immunology.